ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Activist Starboard steps up revolt on Bristol-Celgene merger—and BMS strikes back
March 08, 2019First came the news that activist investor Starboard Value had bought up shares of Bristol-Myers Squibb with the intention of scuttling its planned $74 billion buyout of Celgene. -
Activist Starboard wants to know if Bristol-Myers investors support Celgene buy
February 24, 2019It was only a month after Bristol-Myers Squibb kicked off 2019 by announcing it would buy Celgene for $74 billion that rumors emerged about activist hedge fund Starboard Value taking an interest in the deal—and not necessarily a positive one. Now those mu
Pharma Sources Insight January 2025
